WOS

Permanent URI for this collectionhttps://hdl.handle.net/11443/932

Browse

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Hey Siri! Perform a type 3 hysterectomy. Please watch out for the ureter!'' What is autonomous surgery and what are the latest developments?
    (GALENOS YAYINCILIK, 2021-01-01) Gultekin, Ismail Burak; Karabuk, Emine; Kose, Mehmet Faruk
    As a result of major advances in deep learning algorithms and computer processing power, there have been important developments in the fields of medicine and robotics. Although fully autonomous surgery systems where human impact will be minimized are still a long way off, systems with partial autonomy have gradually entered clinical use. In this review, articles on autonomous surgery classified and summarized, with the aim of informing the reader about questions such as `` What is autonomic surgery?{''} and in which areas studies are progressing.
  • Thumbnail Image
    Item
    An overview of polycystic ovary syndrome in aging women
    (GALENOS YAYINCILIK, 2021-01-01) Celik, Ozlem; Kose, Mehmet Faruk
    The manifestations of polycystic ovary syndrome (PCOS), a ubiquitous reproductive disorder, may vary significantly depending on the severity of a number of endocrine and metabolic changes. Although no diagnostic criteria are presently available for PCOS for perimenopausal and menopausal women, the condition can still be suspected in case of a previous diagnosis of the condition, a chronic history of irregular menstrual cycles and hyperandrogenism, and/or polycystic ovarian morphology during the reproductive period. PCOS is associated with long-term health risks, including obesity, diabetes, hypertension, dyslipidemia, metabolic syndrome and cardiovascular risk factors during reproductive age, especially in patients possessing classic phenotypes. The aim of this review was to outline the available data about the impact of PCOS on long-term health risks after reproductive age in patients with PCOS. Previously, it was assumed that women with PCOS would be more prone to develop cardiometabolic diseases after reproductive age but current data suggest that in accordance with the healing in the phenotypic characteristics of PCOS, no deterioration appears to occur in cardiometabolic health in these patients. While there is substantial evidence for a greater prevalence of abnormal subclinical atherosclerotic markers among younger patients with PCOS, data for older women are insufficient. However, there is also support for an increased risk of endometrial cancer in PCOS patients. Extensive prospective cohort studies in which healthy controls as well as patients with defining PCOS phenotypes are observed and monitored from the early reproductive period into the late postmenopausal period should now be performed in order to clarify morbidities and mortality in aging women with PCOS.